Skip to Main Content

Paper Details

The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance.
Cancer Cell
54
2021
AML, AML cells, AURKB, Aurora kinase B, Cas9, FLT3, FLT3-mutated acute myeloid leukemia, NRAS, NRAS mutant, NRAS mutant subclones, gilteritinib, leukemia, leukemia cells, patients, primary leukemia cells, resistant AML cells, resistant cell cultures, resistant cells, whole
Aniline Compounds, Aurora Kinase B, Biomarkers, Tumor, Drug Resistance, Neoplasm, Exome, Gene Expression Regulation, Neoplastic, Humans, Leukemia, Myeloid, Acute, Metabolome, Protein Kinase Inhibitors, Proteome, Pyrazines, Tumor Cells, Cultured, Tumor Microenvironment
Author NameAffiliation
Sunil K JoshiKnight Cancer Institute, Oregon Health & Science University
Tamilla NechiporukKnight Cancer Institute, Oregon Health & Science University
Daniel BottomlyKnight Cancer Institute, Oregon Health & Science University, Department of Medical Informatics and Clinical Epidemiology
Paul D PiehowskiPacific Northwest National Laboratory
Julie A ReiszUniversity of Colorado Anschutz Medical Campus
Janet PittsenbargerKnight Cancer Institute, Oregon Health & Science University
Andy KaempfKnight Cancer Institute, Oregon Health & Science University
Sara J C GoslinePacific Northwest National Laboratory
Sara J C GoslinePacific Northwest National Laboratory
Yi-Ting WangPacific Northwest National Laboratory
Yi-Ting WangPacific Northwest National Laboratory
Joshua R HansenPacific Northwest National Laboratory
Marina A GritsenkoPacific Northwest National Laboratory
Marina A GritsenkoPacific Northwest National Laboratory
Chelsea HutchinsonPacific Northwest National Laboratory
Karl K WeitzPacific Northwest National Laboratory
Karl K WeitzPacific Northwest National Laboratory
Jamie MoonPacific Northwest National Laboratory
Jamie MoonPacific Northwest National Laboratory
Francesca CendaliUniversity of Colorado Anschutz Medical Campus
Thomas L FillmorePacific Northwest National Laboratory
Chia-Feng TsaiPacific Northwest National Laboratory
Chia-Feng TsaiPacific Northwest National Laboratory
Athena A SchepmoesPacific Northwest National Laboratory
Athena A SchepmoesPacific Northwest National Laboratory
Tujin ShiPacific Northwest National Laboratory
Tujin ShiPacific Northwest National Laboratory
Osama A ArshadPacific Northwest National Laboratory
Osama A ArshadPacific Northwest National Laboratory
Jason E McDermottPacific Northwest National Laboratory
Jason E McDermottPacific Northwest National Laboratory
Ozgun BaburUniversity of Massachusetts
Kevin Watanabe-SmithKnight Cancer Institute, Oregon Health & Science University
Emek DemirKnight Cancer Institute, Oregon Health & Science University
Angelo D'AlessandroUniversity of Colorado Anschutz Medical Campus
Angelo D'AlessandroUniversity of Colorado Anschutz Medical Campus
Tao LiuPacific Northwest National Laboratory
Tao LiuPacific Northwest National Laboratory
Cristina E TognonKnight Cancer Institute, Oregon Health & Science University
Jeffrey W TynerKnight Cancer Institute, Oregon Health & Science University
Shannon K McWeeneyKnight Cancer Institute, Oregon Health & Science University, Department of Medical Informatics and Clinical Epidemiology
Karin D RodlandPacific Northwest National Laboratory, Oregon Health & Science University
Karin D RodlandPacific Northwest National Laboratory, Oregon Health & Science University
Brian J DrukerKnight Cancer Institute, Oregon Health & Science University
Elie TraerKnight Cancer Institute, Oregon Health & Science University
  • 1 - 45

Datasets